IRIS
ACAMPA, MAURIZIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.808
EU - Europa 9.093
AS - Asia 4.978
SA - Sud America 863
Continente sconosciuto - Info sul continente non disponibili 435
AF - Africa 290
OC - Oceania 24
AN - Antartide 1
Totale 26.492
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.582
IT - Italia 1.904
RU - Federazione Russa 1.789
CN - Cina 1.633
SG - Singapore 1.565
GB - Regno Unito 1.426
IE - Irlanda 1.043
DE - Germania 874
BR - Brasile 703
SE - Svezia 595
VN - Vietnam 471
FR - Francia 432
HK - Hong Kong 415
UA - Ucraina 377
FI - Finlandia 257
KR - Corea 248
IN - India 166
ZA - Sudafrica 131
BD - Bangladesh 106
CA - Canada 105
NL - Olanda 68
ES - Italia 65
TR - Turchia 61
MX - Messico 58
AR - Argentina 51
CI - Costa d'Avorio 48
IQ - Iraq 46
JP - Giappone 44
NG - Nigeria 42
PL - Polonia 40
AT - Austria 37
BE - Belgio 31
CZ - Repubblica Ceca 31
EC - Ecuador 29
ID - Indonesia 27
PK - Pakistan 26
GR - Grecia 24
AU - Australia 22
CH - Svizzera 22
IR - Iran 22
VE - Venezuela 18
CO - Colombia 17
KE - Kenya 17
SA - Arabia Saudita 14
CR - Costa Rica 13
PH - Filippine 13
CL - Cile 12
IL - Israele 12
JM - Giamaica 12
UZ - Uzbekistan 12
AE - Emirati Arabi Uniti 11
EG - Egitto 11
LT - Lituania 11
NP - Nepal 10
MA - Marocco 9
PY - Paraguay 9
TN - Tunisia 9
MY - Malesia 8
TH - Thailandia 8
AZ - Azerbaigian 7
BO - Bolivia 7
DZ - Algeria 7
EU - Europa 7
KG - Kirghizistan 7
OM - Oman 7
PE - Perù 7
RO - Romania 7
UY - Uruguay 7
BG - Bulgaria 6
HN - Honduras 6
JO - Giordania 6
LV - Lettonia 6
SI - Slovenia 6
TT - Trinidad e Tobago 6
DO - Repubblica Dominicana 5
EE - Estonia 5
HR - Croazia 5
SV - El Salvador 5
CY - Cipro 4
HU - Ungheria 4
PA - Panama 4
RS - Serbia 4
SC - Seychelles 4
AL - Albania 3
BB - Barbados 3
BY - Bielorussia 3
KZ - Kazakistan 3
MD - Moldavia 3
MU - Mauritius 3
PS - Palestinian Territory 3
PT - Portogallo 3
SN - Senegal 3
SY - Repubblica araba siriana 3
BA - Bosnia-Erzegovina 2
ET - Etiopia 2
GE - Georgia 2
GT - Guatemala 2
GY - Guiana 2
LB - Libano 2
LK - Sri Lanka 2
Totale 26.025
Salva come PNG Salva come JPEG
Città #
Dallas 1.323
Southend 1.165
Dublin 1.007
Singapore 902
Ashburn 900
Fairfield 800
San Jose 669
Santa Clara 530
Moscow 496
Milan 493
Chandler 478
Beijing 403
Hong Kong 401
Hefei 348
Council Bluffs 344
Woodbridge 336
Siena 300
Wilmington 296
Houston 293
Seattle 292
Jacksonville 290
Cambridge 276
Seoul 243
Ann Arbor 234
New York 184
Los Angeles 178
Princeton 178
Menlo Park 173
Rome 144
Helsinki 142
The Dalles 140
Lauterbourg 127
Ho Chi Minh City 120
Johannesburg 117
Florence 114
Munich 112
Nanjing 109
Columbus 106
Hanoi 105
Boardman 93
Dong Ket 90
Dearborn 83
Vimercate 78
Buffalo 73
São Paulo 71
San Diego 65
Shanghai 56
Chicago 53
Orem 53
Bengaluru 50
Abidjan 48
London 48
Nanchang 46
Frankfurt am Main 42
San Mateo 42
Brooklyn 39
Abuja 37
Redondo Beach 35
Tokyo 35
Turku 35
Málaga 34
San Francisco 34
Toronto 34
Turin 33
Warsaw 33
Lappeenranta 31
Pisa 31
Mestre 30
Changsha 29
Poggiomarino 29
Brussels 28
Montreal 28
Nuremberg 28
Denver 27
Shenyang 26
Atlanta 24
Washington 24
Guangzhou 23
Mexico City 23
Paris 23
Amsterdam 22
Da Nang 22
Figino 22
Jiaxing 22
Manchester 22
Tianjin 22
Belo Horizonte 21
Boston 21
Brno 20
Rio de Janeiro 20
Brasília 19
Livorno 19
Chennai 18
Jinan 18
Lancaster 18
Miami 18
Bologna 17
Phoenix 17
Queens 17
Vienna 17
Totale 17.004
Salva come PNG Salva come JPEG
Nome #
Arrhythmogenicity of Anti-Ro/SSA antibodies in patients with torsades de pointes 428
Antiarrhythmic potential of anticytokine therapy in rheumatoid arthritis: tocilizumab reduces corrected QT interval by controlling systemic inflammation 413
Proton pump inhibitors directly block hERG-potassium channel and independently increase the risk of QTc prolongation in a large cohort of US Veterans 383
Systemic Inflammation Rapidly Induces Reversible Atrial Electrical Remodeling: The Role of Interleukin-6–Mediated Changes in Connexin Expression 375
Marked QTc Prolongation and Torsades de pointes in Patients with Chronic Inflammatory Arthritis 372
Proton pump inhibitors and serum magnesium levels in patients with Torsades de Pointes 349
Anti-Ro/SSA-associated corrected QT interval prolongation in adults: the role of antibody level and specificity 326
Association between high sensitivity C-reactive protein, heart rate variability and corrected QT interval in patients with chronic inflammatory arthritis 326
Autonomic activity and baroreflex sensitivity in patients submitted to carotid stenting 316
Anti-Ro/SSA Antibodies Blocking Calcium Channels as a Potentially Reversible Cause of Atrioventricular Block in Adults 312
Spotlight on sirukumab for the treatment of rheumatoid arthritis: The evidence to date 308
P wave dispersion in cryptogenic stroke: A risk factor for cardioembolism? 308
Autoantibody-mediated cardiac arrhythmias: mechanisms and clinical implications 298
Genetic influence in antithrombotic actions of atorvastatin in hypercholesterolaemia 295
Acute effects of glibenclamide on reactive hyperaemia in the lower limbs in humans 292
Systemic thrombolysis for stroke in pregnancy 291
Advanced Atrioventricular Block in Athletes: Prevalence and Role of Anti-Ro/Sjögren Syndrome-Related Antigen A Antibodies 288
Comparison of frequency of complex ventricular arrhythmias in patients with positive versus negative anti-Ro/SSA and connective tissue disease 282
Arrhythmic risk in rheumatoid arthritis: the driving role of systemic inflammation 281
Androgen Deprivation Therapy for Prostatic Cancer in Patients With Torsades de Pointes 281
Predictors of long-term recovery in complex activities of daily living before discharge from the stroke unit 280
Cardiac autonomic nervous system and risk of arrhythmias in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) 279
Delineation of the phenotype associated with 7q36.1q36.2 deletion: long QT syndrome, renal hypoplasia and mental retardation 275
Cardiac dysautonomia and serotonin plasma levels in Rett syndrome 269
Cardiac dysautonomia and arterial distensibility in essential hypertensives 267
Time Course of Corticospinal Excitability and Autonomic Function Interplay during and Following Monopolar tDCS 266
Autonomic dysfunction in mental retardation and spastic paraparesis with MECP2 mutation 262
Relationship between the modified Rankin Scale and the Barthel Index in the process of functional recovery after stroke 259
Torsades de Pointes in patients with polymyalgia rheumatica 257
Neuroimaging and definition of transient ischemic attack 256
Arrhythmic risk during acute infusion of infliximab: a prospective, single-blind, placebo-controlled, cross-over study in patients with chronic arthritis 252
Anticoagulation after Stroke in Patients with Atrial Fibrillation: To Bridge or Not with Low-Molecular-Weight Heparin? 246
Editorial: Insights in General Cardiovascular Medicine: 2021 245
Prolongation of the corrected QT interval in adult patients with anti-Ro/SSA positive connective tissue diseases 245
Double ophthalmic arteries arising from the internal carotid artery. A case report of a hidden second ophthalmic artery 245
Aortic stiffness in patients with deep and lobar intracerebral hemorrhage: role of antihypertensive drugs and statins: response to letter 242
Cardiac arrest risk during acute infections: systemic inflammation directly prolongs QTc interval via cytokine-mediated effects on potassium channel expression 240
Arrhythmogenic effects of anti-Ro/SSA antibodies on theadult heart: more than expected? 238
Cardiac dysautonomia in patients with superior vena cava syndrome due to compression by lung cancer. 235
Connective tissue diseases and cardiac rhythm disorders: an overview 234
Increased arterial stiffness is an independent risk factor for hemorrhagic transformation in ischemic stroke undergoing thrombolysis 232
Microvascular abnormalities in Rett Syndrome 226
Pravastatin treatment-associated reduction in plasma homocysteine in heart-transplanted patients 225
Prediction of Early Recurrent Thromboembolic Event and Major Bleeding in Patients With Acute Stroke and Atrial Fibrillation by a Risk Stratification Schema: The ALESSA Score Study 224
Atrial cardiopathy and sympatho-vagal imbalance in cryptogenic stroke: Pathogenic mechanisms and effects on electrocardiographic markers 224
Causes and Risk Factors of Cerebral Ischemic Events in Patients with Atrial Fibrillation Treated with Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention: The RENo Study 223
Thrombolytic treatment of cardiac myxoma-induced ischemic stroke: a review 223
Early and delayed increase in plasma homocysteine levels in heart transplanted patients 221
Stroke warning syndrome: 18 new cases 221
Endovascular treatment of early recurrent ischemic stroke following intravenous thrombolysis 218
Safety of intravenous thrombolysis in ischemic stroke caused by left atrial myxoma 214
Cranial osteolytic metastases as the only recurrence of gastric carcinoma 213
Bosentan treatment on Raynaud Phenomenon and Skin Fibrosis in Patients with Systemic Sclerosis and with Pulmonary Arterial Hypertension: an open-label, observational, retrospective study 211
Transient hypogonadism is associated with heart rate-corrected QT prolongation and torsades de pointes risk during active systemic inflammation in men 209
How to Identify Patients at Risk of Silent Atrial Fibrillation after Cryptogenic Stroke: Potential Role of P Wave Dispersion 205
Safety of anticoagulation in patients treated with urgent reperfusion for ischemic stroke related to atrial fibrillation 205
Inflammatory cytokines, life-threatening arrhythmias and premature mortality in chronic inflammatory arthritis: Time to focus on 201
Elevated Interleukin-6 Levels Are Associated With an Increased Risk of QTc Interval Prolongation in a Large Cohort of US Veterans 199
Electromagnetic fields produced by incubators influence heart rate variability in newborns 197
Anticoagulation in acute ischemic stroke patients with mechanical heart valves: To bridge or not with heparin. The ESTREM study 196
Early recurrence and major bleeding in patients with acute ischemic stroke and atrial fibrillation treated with Non-Vitamin-K oral anticoagulants (RAF-NOACs) Study 196
Previous use of statins and atrial electrical remodeling in patients with cryptogenic stroke 195
Pharmacogenetics of statins therapy 194
Hemorrhagic transformation in patients with acute ischemic stroke and atrial fibrillation: Time to initiation of oral anticoagulant therapy and outcomes 193
Acute ischemic stroke and concomitant massive pulmonary embolism: a challenge 190
Interleukin-6 elevation Is a key pathogenic factor underlying COVID-19-associated heart rate-corrected QT interval prolongation 186
Sympathetic overactivity and plasma leptin levels in Rett syndrome 186
P wave dispersion and silent atrial fibrillation in cryptogenic stroke: The pathogenic role of inflammation 182
Oral low-dose dipyridamole protects from intravenous high-dose dipyridamole-induced ischemia. A oral echocardiographic study 180
Letter regarding “Combined aspiration thrombectomy and continuous intrasinus thrombolysis for cerebral venous sinus thrombosis: technical note and case series” 178
Nerve growth factor plasma levels and ventricular repolarization in Rett syndrome 176
Early recurrence in paroxysmal versus sustained atrial fibrillation in patients with acute ischaemic stroke 174
Long-Term Risk of Arterial Thrombosis after Intracerebral Hemorrhage: MUCH-Italy 172
Effects of acetyl-L-carnitine on cardiac dysautonomia in Rett syndrome: prevention of sudden death? 171
Sudden death and cardiac arrhythmias in Rett syndrome 171
Reperfusion therapies in patients with acute ischaemic stroke and atrial fibrillation: data on safety and effectiveness from a multi-centre cohort study 169
The Impact of Sex and Arterial Stiffness Interactions on the Outcome after an Acute Ischemic Stroke: A Retrospective Cohort Study 166
Homocysteine and P wave dispersion in patients with heart transplantation 165
Corrected QT interval in anti-SSA-positive adults with connective tissue disease: Comment on the article by Lazzerini et al. [6] (multiple letters) 163
Editorial: Insights in general cardiovascular medicine: 2022 161
Increased interleukin-6 levels are associated with atrioventricular conduction delay in severe COVID-19 patients 159
Risk of qtc interval prolongation associated with circulating anti-ro/ssa antibodies among us veterans: an observational cohort study 159
Statin use and long-term risk of recurrent intracerebral haemorrhage: the MUCH-Italy 158
Single-center experience using the 3MAX or 4MAX reperfusion catheter for the treatment of acute ischemic stroke with distal arterial occlusions in patients not eligible for intravenous fibrinolysis 155
Early seizures and risk of epilepsy and death after intracerebral haemorrhage: the MUCH Italy 155
Electrocardiographic Predictors of Silent Atrial Fibrillation in Cryptogenic Stroke 153
The risk of stroke recurrence in patients with atrial fibrillation and reduced ejection fraction 150
Increased Arterial Stiffness is a Predictor of Delayed Ischaemic Stroke After Subarachnoid Haemorrhage 150
Maternal Anti-Ro/SSA Autoantibodies and Prolonged PR Interval in a Competitive Athlete: Beyond Training-Induced Electrical Remodeling 148
Practical "1-2-3-4-Day" Rule for Starting Direct Oral Anticoagulants After Ischemic Stroke With Atrial Fibrillation: Combined Hospital-Based Cohort Study 148
Prevalence of Fabry disease and GLA variants in young patients with acute stroke: the challenge to widen the screening. The Fabry-Stroke Italian Registry 148
Effects of acute administration of iloprost on the cardiac autonomic nervous system and ventricular repolarisation in patients with systemic sclerosis 147
Ischemic stroke after heart transplantation 147
Editorial: New challenges and future perspectives in autonomic neuroscience 146
Increased arterial stiffness is associated with poor collaterals in acute ischemic stroke from large vessel occlusion 146
Autonomic nervous system alterations in Rett syndrome 146
Cardiac disease and Rett syndrome 145
Risk of recurrent stroke in patients with atrial fibrillation treated with oral anticoagulants alone or in combination with anti-platelet therapy 144
Editorial: Year in review: discussions in general cardiovascular medicine 142
Markers of atrial cardiopathy in severe embolic strokes of undetermined source 141
Totale 22.458
Salva come PNG Salva come JPEG
Categoria #
all - tutte 86.792
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 86.792
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.290 0 0 54 130 78 27 56 154 123 128 226 314
2022/20231.837 114 218 247 233 148 339 72 130 150 60 85 41
2023/20242.013 62 27 158 111 87 499 558 47 34 51 118 261
2024/20253.941 105 185 351 319 422 225 178 223 362 181 399 991
2025/20269.690 713 1.308 988 1.069 1.660 359 1.120 311 333 545 368 916
2026/20271.311 450 535 326 0 0 0 0 0 0 0 0 0
Totale 26.492